| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Challenges for drug studies in children: CYP3A phenotyping as example
|
de Wildt, Saskia N.
|
|
2009
|
14 |
1-2 |
p. 6-15
10 p.
|
artikel
|
| 2 |
Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway
|
Gunthorpe, Martin J.
|
|
2009
|
14 |
1-2 |
p. 56-67
12 p.
|
artikel
|
| 3 |
Contents
|
|
|
2009
|
14 |
1-2 |
p. i-
1 p.
|
artikel
|
| 4 |
Contents
|
|
|
2009
|
14 |
1-2 |
p. iii-
1 p.
|
artikel
|
| 5 |
Correct assessment of new compounds using in vivo screening models can reduce false positives
|
Bueters, Tjerk J.H.
|
|
2009
|
14 |
1-2 |
p. 89-94
6 p.
|
artikel
|
| 6 |
3D cell culture opens new dimensions in cell-based assays
|
Justice, Bradley A.
|
|
2009
|
14 |
1-2 |
p. 102-107
6 p.
|
artikel
|
| 7 |
Drug discovery: new models for industry–academic partnerships
|
Tralau-Stewart, Cathy J.
|
|
2009
|
14 |
1-2 |
p. 95-101
7 p.
|
artikel
|
| 8 |
How do we assure the quality of biological medicines?
|
Longstaff, Colin
|
|
2009
|
14 |
1-2 |
p. 50-55
6 p.
|
artikel
|
| 9 |
In search of negative allosteric modulators of biological targets
|
Groebe, Duncan R.
|
|
2009
|
14 |
1-2 |
p. 41-49
9 p.
|
artikel
|
| 10 |
Is there a case for selectively promiscuous anticancer drugs?
|
Fernández, Ariel
|
|
2009
|
14 |
1-2 |
p. 1-5
5 p.
|
artikel
|
| 11 |
Metabolic engineering of microorganisms: general strategies and drug production
|
Lee, Sang Yup
|
|
2009
|
14 |
1-2 |
p. 78-88
11 p.
|
artikel
|
| 12 |
‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries
|
Dobson, Paul D.
|
|
2009
|
14 |
1-2 |
p. 31-40
10 p.
|
artikel
|
| 13 |
β2-Microglobulin: emerging as a promising cancer therapeutic target
|
Shi, Chunmeng
|
|
2009
|
14 |
1-2 |
p. 25-30
6 p.
|
artikel
|
| 14 |
Plant-produced vaccines: promise and reality
|
Rybicki, Edward P.
|
|
2009
|
14 |
1-2 |
p. 16-24
9 p.
|
artikel
|
| 15 |
The use of combinatorial chemistry methodologies to discover novel chemotherapeutic agents
|
Edwards, Paul J.
|
|
2009
|
14 |
1-2 |
p. 108-110
3 p.
|
artikel
|
| 16 |
Value networks identify innovation in 21st century pharmaceutical research
|
Edwards, Paul J.
|
|
2009
|
14 |
1-2 |
p. 68-77
10 p.
|
artikel
|
Tijdschrift beschrijving